Text Size

Diurnal Triglyceridemia in Relation to Alcohol Intake

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ana Torres do Rego, Sint Franciscus Gasthuis
ClinicalTrials.gov Identifier:
NCT01786421
First received: January 29, 2013
Last updated: February 5, 2013
Last verified: February 2013
History of Changes
  Purpose

The purpose of this study is to determine the impact of alcohol consumption in diurnal triglyceridemia in a free living situation.


Condition
Healthy Subjects
Hyperlipidemias
Type 2 Diabetes Mellitus
Cardiovascular Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Observational Study of Diurnal Triglyceridemia in Relation to Alcohol Intake

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Sint Franciscus Gasthuis:

Primary Outcome Measures:
  • Determination of diurnal triglyceridemia depend on alcohol intake [ Time Frame: For 3 days. ] [ Designated as safety issue: No ]
    Capillary triglyceridemia was measured by a triglyceride testing device on six fixed time-points.


Secondary Outcome Measures:
  • Gender differences in diurnal triglyceridemia by alcohol consumption [ Time Frame: For 3 days ] [ Designated as safety issue: No ]

Enrollment: 273
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
Groups/Cohorts
General population
Healthy volunteers,patients with hyperlipidemia,a known medical history of cardiovascular diseases or type 2 diabetes mellitus.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Subjects were healthy volunteers or patients with hyperlipidemia or a known medical history of cardiovascular diseases, type 2 diabetes mellitus participating in several clinical studies with the same protocol, aimed to investigate factors influencing postprandial lipemia

Criteria

Inclusion Criteria:

  • Healthy volunteers

Patients with:

  • Hyperlipidemia
  • Type 2 Diabetes Mellitus
  • Cardiovascular diseases

Exclusion Criteria:

  • Renal disease
  • Liver disease
  • Thyroid disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01786421

Locations
Netherlands
Sint Franciscus Gasthuis
Rotterdam, Netherlands, 10900
Utrecht University Medical Center
Utrecht, Netherlands
Sponsors and Collaborators
Sint Franciscus Gasthuis
  More Information

No publications provided

Responsible Party: Ana Torres do Rego, Medical Doctor, Sint Franciscus Gasthuis
ClinicalTrials.gov Identifier: NCT01786421     History of Changes
Other Study ID Numbers: AlcoholTG_SFG_2013
Study First Received: January 29, 2013
Last Updated: February 5, 2013
Health Authority: Netherlands: Dutch Health Care Inspectorate

Keywords provided by Sint Franciscus Gasthuis:
Ethanol
Lipemia
Postprandial
Triglyceride

Additional relevant MeSH terms:
Alcohol Drinking
Cardiovascular Diseases
Diabetes Mellitus
Diabetes Mellitus, Type 2
Hyperlipidemias
Drinking Behavior
 Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Dyslipidemias
Lipid Metabolism Disorders

ClinicalTrials.gov processed this record on May 22, 2013